Many people do not realize that COVID-19 can affect more than a patient’s lungs. As more and more research on the affects of COVID-19 disseminates, we are finding out that the disease also has the potential to cause long term…
Executive Summary Multiple-of-Medicare (“MoM”) repricing is a popular and common cost containment strategy used by many plans and repricing companies for dialysis claims repricing. Renalogic has intentionally chosen to stay away from MoM methods because of the high risk of…
Newsweek Magazine ArticleBy: David H. Freedman Before the pandemic, the plan would have seemed like something ripped from a distant dystopian future in which the human race fully surrenders to Big Tech. On the April 10 online document, the logos…
The central mission of Renalogic has always been to drive positive change for kidney disease and help members thrive while living with chronic conditions. These values hold even more now with our member’s lives so significantly impacted by the COVID-19…
Health Benefits Risk Management at the Intersection of Monopoly and Intensive Regulation The dialysis sector is an intensified microcosm of the American health care system, and that’s bad for self-insured plans in particular. On the one hand, the dialysis marketplace…
As the leader in chronic kidney disease (“CKD”) case management for self-funded employers, we are thrilled by the new Executive Order directing Medicare to develop payment models encouraging providers to identify and treat Medicare beneficiaries who have late-stage CKD, to…
Renalogic - All Rights Reserved 2020
